Home » Archives for Stem cell controversy
Posted by N4CM
Biotechnology
15 Dec 2011
Source: Nature. It was overcast and unseasonably sultry in Luxembourg, home to the European Court of Justice, on the morning of 18 October 2011. But German neuroscientist Oliver Brüstle wasn’t sweating when the 13 judges entered the court room in their flowing crimson robes. Not, that is, until they delivered their verdict, which spelt the end of his lengthy fight to defend his patent on human embryonic stem (ES) cells from attack by Greenpeace.
Posted by N4CM
Biotechnology
24 Nov 2011
Source: NEJM.org. Until recently, it seemed as if the question of future federal funding for embryonic stem-cell research had been settled. The Obama administration had lifted President George W. Bush’s previous restrictions on funding, and the legality of that decision was upheld by federal courts. But the 2012 presidential election campaign has once again raised uncertainty about such funding.
Posted by N4CM
News, Top Stories
15 Nov 2011
Source: The Washington Post. The company conducting the first government-approved tests in people of a therapy developed using human embryonic stem cells abruptly announced Monday that it was halting the study, stunning advocates of the highly contentious field. Geron Corp. of Menlo Park, Calif., said the move, which stops one of the most controversial and closely watched medical experiments in the [...]
Posted by N4CM
Biotechnology
15 Aug 2011
Source: Stanford Law School. Earlier this morning, Judge Royce Lamberth issued an opinion and order granting summary judgment to the NIH in Sherley v. Sibelius and denying summary judgment to the plaintiffs. This is another step toward ending the uncertainty about the legality of federal funding of such research, uncertainty largely created by Judge Lamberth on August 23, 2010.
Posted by N4CM
Biotechnology, News, Top Stories
26 Jun 2011
Source: The Telegraph. Scientists have found they can create chimeric animals that have organs belonging to another species by injecting stem cells into the embryo of another species. The researchers injected stem cells from rats into the embryos of mice that had been genetically altered so they could not produce their own organs, creating mice that had rat organs.
Posted by N4CM
Books, Highlights
30 May 2011
Excerpt from Nobel Laureate Harold Varmus’s book, “The Art and Politics of Science”. A Nobel Prize-winning cancer biologist, leader of major scientific institutions, and former scientific adviser to President Obama reflects on his remarkable career. From this truly unique perspective, Varmus shares his experiences from the trenches of politicised battlegrounds ranging from budget fights to stem cell research, global health to science publishing.
Posted by N4CM
Biotechnology
30 May 2011
Source: AnnArbor.com. A preeminent figure in embryonic stem cell research is leaving the state. And Sean Morrison, director of the Center for Stem Cell Biology at the University of Michigan, isn’t mincing words on his way out the door. Since news broke of his pending departure to lead a new pediatric research initiative at University of Texas Southwestern Medical School in Dallas, [...]
Posted by N4CM
Biotechnology, Opinion
27 Mar 2011
Source: shreveporttimes.com. We should move beyond the embryo debate to a much wider array of ethical issues in basic stem cell science and clinical translational research where there are potential ethical costs to individuals whom everyone would agree are full moral persons with rights and interests.
Posted by N4CM
Biotechnology
11 Jan 2011
ALS is a diagnosis that can be a death-sentence — a disease with no cure. But new research could change that. The treatment is at the center of controversy: an embryonic stem cell transplant. Doctors in Atlanta are studying how well it works, and are calling it groundbreaking. But others say it is morally wrong. In this special report, we look at the different sides of the stem cell debate.
Posted by N4CM
Biotechnology
13 Oct 2010
Source: The New York Times. Rushing to work at Cincinnati Children’s Hospital Medical Center one recent morning, Jason Spence, 33, grabbed a moment during breakfast to type “stem cells” into Google and click for the last 24 hours of news. It is a routine he has performed daily in the six weeks since a Federal District Court ruling put the future of his research in jeopardy.